HINT2
Basic information
Region (hg38): 9:35812960-35815354
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HINT2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 10 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 8 | 2 | 0 |
Variants in HINT2
This is a list of pathogenic ClinVar variants found in the HINT2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-35813080-G-A | not specified | Uncertain significance (Oct 04, 2024) | ||
9-35813080-G-C | not specified | Uncertain significance (Oct 16, 2024) | ||
9-35813082-C-A | not specified | Uncertain significance (Dec 03, 2024) | ||
9-35813139-T-C | not specified | Uncertain significance (Apr 12, 2023) | ||
9-35813280-T-A | not specified | Uncertain significance (Oct 03, 2024) | ||
9-35813454-T-G | not specified | Likely benign (Sep 25, 2023) | ||
9-35813462-C-T | not specified | Uncertain significance (Mar 14, 2023) | ||
9-35813464-G-T | not specified | Uncertain significance (Apr 26, 2024) | ||
9-35813476-C-T | not specified | Uncertain significance (May 08, 2024) | ||
9-35813524-G-A | not specified | Uncertain significance (Apr 22, 2024) | ||
9-35813693-C-T | not specified | Uncertain significance (Jan 23, 2023) | ||
9-35813700-A-T | not specified | Uncertain significance (Oct 17, 2023) | ||
9-35813762-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
9-35814907-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
9-35814963-A-C | not specified | Uncertain significance (Dec 03, 2024) | ||
9-35814969-G-A | not specified | Likely benign (Feb 06, 2023) | ||
9-35814969-G-C | not specified | Uncertain significance (Jan 23, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HINT2 | protein_coding | protein_coding | ENST00000259667 | 5 | 2395 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000535 | 0.259 | 125682 | 1 | 65 | 125748 | 0.000262 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.353 | 95 | 85.8 | 1.11 | 0.00000459 | 1018 |
Missense in Polyphen | 29 | 32.035 | 0.90526 | 362 | ||
Synonymous | 0.474 | 29 | 32.4 | 0.894 | 0.00000154 | 364 |
Loss of Function | -0.00585 | 8 | 7.98 | 1.00 | 4.25e-7 | 87 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000612 | 0.000612 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000281 | 0.000281 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000653 | 0.000621 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolase probably involved in steroid biosynthesis. May play a role in apoptosis. Has adenosine phosphoramidase activity. {ECO:0000269|PubMed:16762638, ECO:0000269|PubMed:18653718}.;
Recessive Scores
- pRec
- 0.0837
Intolerance Scores
- loftool
- 0.631
- rvis_EVS
- -0.08
- rvis_percentile_EVS
- 47.79
Haploinsufficiency Scores
- pHI
- 0.0975
- hipred
- N
- hipred_score
- 0.167
- ghis
- 0.438
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.801
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hint2
- Phenotype
- liver/biliary system phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- steroid biosynthetic process;apoptotic process;lipid catabolic process;negative regulation of peptidyl-lysine acetylation
- Cellular component
- nucleolus;mitochondrion
- Molecular function
- nucleotide binding;hydrolase activity